Almirall boosts dermatology with Poli deal

7 December 2015 - Deborah Wilkes

Archived

Almirall is strengthening its presence in dermatology by acquiring Poli Group in a deal worth €365 million (US$395 million) plus potential additional earn-out payments. The Spanish company said the transaction would reinforce "significantly" its OTC presence in Germany, where Poli Group owns Taurus Pharma.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: